Shanghai Henlius Biotech’s Collaboration and License Agreement with Palleon Pharmaceuticals

Fangda advised Shanghai Henlius Biotech, Inc. on the deal.Shanghai Henlius Biotech, Inc. (“Henlius”, 2696.HK) secured a collaboration and license agreement with Palleon Pharmaceuticals (“Palleon”) to develop…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here